The DOI matches its Crossref record; 120 of the 120 references it cites were found in a registry or an index.
Migrastatics—Anti-metastatic and Anti-invasion Drugs: Promises and Challenges
Open accessAbstract
In solid cancers, invasion and metastasis account for more than 90% of mortality. However, in the current armory of anticancer therapies, a specific category of anti-invasion and antimetastatic drugs is missing. Here, we coin the term 'migrastatics' for drugs interfering with all modes of cancer cell invasion and metastasis, to distinguish this class from conventional cytostatic drugs, which are mainly directed against cell proliferation. We define actin polymerization and contractility as target mechanisms for migrastatics, and review candidate migrastatic drugs. Critical assessment of these antimetastatic agents is warranted, because they may define new options for the treatment of solid cancers.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Hallmarks of Cancer: The Next Generation
Hanahan, D., & Weinberg, R. A. (2011) · Cell · doi:10.1016/j.cell.2011.02.013 · Cited by 66,590
Nowell, P. C. (1976) · Science · doi:10.1126/science.959840 · Cited by 6,471
Tumor-Associated Macrophages: From Mechanisms to Therapy
Noy, R., & Pollard, J. W. (2014) · Immunity · doi:10.1016/j.immuni.2014.06.010 · Cited by 4,089
Tumour-cell invasion and migration: diversity and escape mechanisms
Friedl, P., & Wolf, K. (2003) · Nature Reviews Cancer · doi:10.1038/nrc1075 · Cited by 3,222
Specificity and mechanism of action of some commonly used protein kinase inhibitors
DAVIES, S. P., REDDY, H., CAIVANO, M., & COHEN, P. (2000) · Biochemical Journal · doi:10.1042/bj3510095 · Cited by 3,132
Regulation of Myosin Phosphatase by Rho and Rho-Associated Kinase (Rho-Kinase)
Kimura, K., Ito, M., Amano, M., Chihara, K., Fukata, Y., Nakafuku, M., Yamamori, B., Feng, J., Nakano, T., Okawa, K., et al. (1996) · Science · doi:10.1126/science.273.5272.245 · Cited by 2,884
Calcium sensitization of smooth muscle mediated by a Rho-associated protein kinase in hypertension
Uehata, M., Ishizaki, T., Satoh, H., Ono, T., Kawahara, T., Morishita, T., Tamakawa, H., Yamagami, K., Inui, J., Maekawa, M., et al. (1997) · Nature · doi:10.1038/40187 · Cited by 2,859
iRECIST: guidelines for response criteria for use in trials testing immunotherapeutics
Seymour, L., Bogaerts, J., Perrone, A., Ford, R., Schwartz, L. H., Mandrekar, S., Lin, N. U., Litière, S., Dancey, J., Chen, A., et al. (2017) · The Lancet Oncology · doi:10.1016/s1470-2045(17)30074-8 · Cited by 2,472
Phosphorylation and Activation of Myosin by Rho-associated Kinase (Rho-kinase)
Amano, M., Ito, M., Kimura, K., Fukata, Y., Chihara, K., Nakano, T., Matsuura, Y., & Kaibuchi, K. (1996) · Journal of Biological Chemistry · doi:10.1074/jbc.271.34.20246 · Cited by 2,008
Microtubule-binding agents: a dynamic field of cancer therapeutics
Dumontet, C., & Jordan, M. A. (2010) · Nature Reviews Drug Discovery · doi:10.1038/nrd3253 · Cited by 1,718
Actin-Based Cell Motility and Cell Locomotion
Mitchison, T. J., & Cramer, L. P. (1996) · Cell · doi:10.1016/s0092-8674(00)81281-7 · Cited by 1,532
Compensation mechanism in tumor cell migration
Wolf, K., Mazo, I., Leung, H., Engelke, K., von Andrian, U. H., Deryugina, E. I., Strongin, A. Y., Bröcker, E.-B., & Friedl, P. (2003) · The Journal of Cell Biology · doi:10.1083/jcb.200209006 · Cited by 1,391
Steeg, P. S. (2016) · Nature Reviews Cancer · doi:10.1038/nrc.2016.25 · Cited by 1,363
Impact of Natural Products on Developing New Anti-Cancer Agents
Cragg, G. M., Grothaus, P. G., & Newman, D. J. (2009) · Chemical Reviews · doi:10.1021/cr900019j · Cited by 1,302
Sahai, E., & Marshall, C. J. (2003) · Nature Cell Biology · doi:10.1038/ncb1019 · Cited by 1,147
Regulation of the actin cytoskeleton in cancer cell migration and invasion
Yamaguchi, H., & Condeelis, J. (2007) · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · doi:10.1016/j.bbamcr.2006.07.001 · Cited by 1,144
Classifying collective cancer cell invasion
Friedl, P., Locker, J., Sahai, E., & Segall, J. E. (2012) · Nature Cell Biology · doi:10.1038/ncb2548 · Cited by 963
Rac Activation and Inactivation Control Plasticity of Tumor Cell Movement
Sanz-Moreno, V., Gadea, G., Ahn, J., Paterson, H., Marra, P., Pinner, S., Sahai, E., & Marshall, C. J. (2008) · Cell · doi:10.1016/j.cell.2008.09.043 · Cited by 959
Self-citationActin cortex mechanics and cellular morphogenesis
Salbreux, G., Charras, G., & Paluch, E. (2012) · Trends in Cell Biology · doi:10.1016/j.tcb.2012.07.001 · Cited by 871
Actin in dendritic spines: connecting dynamics to function
Hotulainen, P., & Hoogenraad, C. C. (2010) · Journal of Cell Biology · doi:10.1083/jcb.201003008 · Cited by 815
Bubb, M. R., Senderowicz, A. M., Sausville, E. A., Duncan, K. L., & Korn, E. D. (1994) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(17)36545-6 · Cited by 811
Nakagawa, O., Fujisawa, K., Ishizaki, T., Saito, Y., Nakao, K., & Narumiya, S. (1996) · FEBS Letters · doi:10.1016/0014-5793(96)00811-3 · Cited by 802
Modes of cancer cell invasion and the role of the microenvironment
Clark, A. G., & Vignjevic, D. M. (2015) · Current Opinion in Cell Biology · doi:10.1016/j.ceb.2015.06.004 · Cited by 761
Totsukawa, G., Yamakita, Y., Yamashiro, S., Hartshorne, D. J., Sasaki, Y., & Matsumura, F. (2000) · The Journal of Cell Biology · doi:10.1083/jcb.150.4.797 · Cited by 689
An essential part for Rho–associated kinase in the transcellular invasion of tumor cells
Itoh, K., Yoshioka, K., Akedo, H., Uehata, M., Ishizaki, T., & Narumiya, S. (1999) · Nature Medicine · doi:10.1038/5587 · Cited by 600
The actin cytoskeleton in cancer cell motility
Olson, M. F., & Sahai, E. (2009) · Clinical & Experimental Metastasis · doi:10.1007/s10585-008-9174-2 · Cited by 572
Movers and shakers: cell cytoskeleton in cancer metastasis
Fife, C. M., McCarroll, J. A., & Kavallaris, M. (2014) · British Journal of Pharmacology · doi:10.1111/bph.12704 · Cited by 551
ROCK and JAK1 Signaling Cooperate to Control Actomyosin Contractility in Tumor Cells and Stroma
Sanz-Moreno, V., Gaggioli, C., Yeo, M., Albrengues, J., Wallberg, F., Viros, A., Hooper, S., Mitter, R., Féral, C. C., Cook, M., et al. (2011) · Cancer Cell · doi:10.1016/j.ccr.2011.06.018 · Cited by 409
Self-citationCdc42–MRCK and Rho–ROCK signalling cooperate in myosin phosphorylation and cell invasion
Wilkinson, S., Paterson, H. F., & Marshall, C. J. (2005) · Nature Cell Biology · doi:10.1038/ncb1230 · Cited by 390
Rho Kinase (ROCK) Inhibitors and Their Therapeutic Potential
Feng, Y., LoGrasso, P. V., Defert, O., & Li, R. (2016) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.5b00683 · Cited by 378
Bronsert, P., Enderle‐Ammour, K., Bader, M., Timme, S., Kuehs, M., Csanadi, A., Kayser, G., Kohler, I., Bausch, D., Hoeppner, J., et al. (2014) · The Journal of Pathology · doi:10.1002/path.4416 · Cited by 341
The molecular mechanisms of transition between mesenchymal and amoeboid invasiveness in tumor cells
Paňková, K., Rösel, D., Novotný, M., & Brábek, J. (2010) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-009-0132-1 · Cited by 333
Self-citationBiomechanical regulation of contractility: spatial control and dynamics
Levayer, R., & Lecuit, T. (2012) · Trends in Cell Biology · doi:10.1016/j.tcb.2011.10.001 · Cited by 324
Designing a broad-spectrum integrative approach for cancer prevention and treatment
Block, K. I., Gyllenhaal, C., Lowe, L., Amedei, A., Amin, A. R. M. R., Amin, A., Aquilano, K., Arbiser, J., Arreola, A., Arzumanyan, A., et al. (2015) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2015.09.007 · Cited by 300
Self-citationActin-Latrunculin A Structure and Function
Yarmola, E. G., Somasundaram, T., Boring, T. A., Spector, I., & Bubb, M. R. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.m004253200 · Cited by 270
Rho-Kinase Inhibitor Retards Migration and in Vivo Dissemination of Human Prostate Cancer Cells
Somlyo, A. V., Bradshaw, D., Ramos, S., Murphy, C., Myers, C. E., & Somlyo, A. P. (2000) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.2000.2343 · Cited by 241
The promise of sonodynamic therapy
Trendowski, M. (2014) · Cancer and Metastasis Reviews · doi:10.1007/s10555-013-9461-5 · Cited by 228
What are the hallmarks of cancer?
Lazebnik, Y. (2010) · Nature Reviews Cancer · doi:10.1038/nrc2827 · Cited by 227
A role for LIM kinase in cancer invasion
Yoshioka, K., Foletta, V., Bernard, O., & Itoh, K. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1232344100 · Cited by 215
Arozarena, I., Sanchez-Laorden, B., Packer, L., Hidalgo-Carcedo, C., Hayward, R., Viros, A., Sahai, E., & Marais, R. (2011) · Cancer Cell · doi:10.1016/j.ccr.2010.10.029 · Cited by 212
Small-Molecule Inhibitors of Actin Dynamics and Cell Motility
Fenteany, G., & Zhu, S. (2003) · Current Topics in Medicinal Chemistry · doi:10.2174/1568026033452348 · Cited by 208
Novel Insights into the Roles of Rho Kinase in Cancer
Wei, L., Surma, M., Shi, S., Lambert-Cheatham, N., & Shi, J. (2016) · Archivum Immunologiae et Therapiae Experimentalis · doi:10.1007/s00005-015-0382-6 · Cited by 205
Cancer metastasis as a therapeutic target
Sleeman, J., & Steeg, P. S. (2010) · European Journal of Cancer · doi:10.1016/j.ejca.2010.02.039 · Cited by 198
Actin-targeting natural products: structures, properties and mechanisms of action
Allingham, J. S., Klenchin, V. A., & Rayment, I. (2006) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-006-6157-9 · Cited by 197
The role of the tissue microenvironment in the regulation of cancer cell motility and invasion
Brábek, J., Mierke, C. T., Rösel, D., Veselý, P., & Fabry, B. (2010) · Cell Communication and Signaling · doi:10.1186/1478-811x-8-22 · Cited by 186
Self-citationKümper, S., Mardakheh, F. K., McCarthy, A., Yeo, M., Stamp, G. W., Paul, A., Worboys, J., Sadok, A., Jørgensen, C., Guichard, S., et al. (2016) · eLife · doi:10.7554/elife.12203 · Cited by 186
Voorneveld, P. W., Kodach, L. L., Jacobs, R. J., Liv, N., Zonnevylle, A. C., Hoogenboom, J. P., Biemond, I., Verspaget, H. W., Hommes, D. W., de Rooij, K., et al. (2014) · Gastroenterology · doi:10.1053/j.gastro.2014.03.052 · Cited by 183
The Rho kinase inhibitor fasudil inhibits tumor progression in human and rat tumor models
Ying, H., Biroc, S. L., Li, W.-W., Alicke, B., Xuan, J.-A., Pagila, R., Ohashi, Y., Okada, T., Kamata, Y., & Dinter, H. (2006) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-05-0440 · Cited by 182
Jasplakinolide: An Actin-Specific Reagent that Promotes Actin Polymerization
Holzinger, A. (2009) · Methods in Molecular Biology · doi:10.1007/978-1-60761-376-3_4 · Cited by 174
A Novel Class of Anticancer Compounds Targets the Actin Cytoskeleton in Tumor Cells
Stehn, J. R., Haass, N. K., Bonello, T., Desouza, M., Kottyan, G., Treutlein, H., Zeng, J., Nascimento, P. R. B. B., Sequeira, V. B., Butler, T. L., et al. (2013) · Cancer Research · doi:10.1158/0008-5472.can-12-4501 · Cited by 169
Salhia, B., Rutten, F., Nakada, M., Beaudry, C., Berens, M., Kwan, A., & Rutka, J. T. (2005) · Cancer Research · doi:10.1158/0008-5472.can-05-0160 · Cited by 167
Ikenoya, M., Hidaka, H., Hosoya, T., Suzuki, M., Yamamoto, N., & Sasaki, Y. (2002) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.2002.00801.x · Cited by 161
Patel, R. A., Forinash, K. D., Pireddu, R., Sun, Y. H., Sun, N., Martin, M. P., Schönbrunn, E., Lawrence, N. J., & Sebti, S. M. (2012) · Cancer Research · doi:10.1158/0008-5472.can-12-0954 · Cited by 149
Characterization of the activities of actin-affecting drugs on tumor cell migration
Hayot, C., Debeir, O., Ham, P. V., Damme, M. V., Robert Kiss, A., & Decaestecker, C. (2005) · Toxicology and Applied Pharmacology · doi:10.1016/j.taap.2005.06.006 · Cited by 148
Rho Kinase Inhibitors Block Melanoma Cell Migration and Inhibit Metastasis
Sadok, A., McCarthy, A., Caldwell, J., Collins, I., Garrett, M. D., Yeo, M., Hooper, S., Sahai, E. A., Kuemper, S., Mardakheh, F. K., et al. (2015) · Cancer Research · doi:10.1158/0008-5472.can-14-2156 · Cited by 147
Kunze, B., Jansen, R., Sasse, F., Höfle, G., & Reichenbach, H. (1995) · The Journal of Antibiotics · doi:10.7164/antibiotics.48.1262 · Cited by 136
Ion channels and transporters in tumour cell migration and invasion
Schwab, A., & Stock, C. M. (2014) · Philosophical Transactions of the Royal Society B Biological Sciences · doi:10.1098/rstb.2013.0102 · Cited by 131
Dynamic and structural signatures of lamellar actomyosin force generation
Aratyn-Schaus, Y., Oakes, P. W., & Gardel, M. L. (2011) · Molecular Biology of the Cell · doi:10.1091/mbc.e10-11-0891 · Cited by 123
Regulation of actin dynamics is critical for endothelial barrier functions
Waschke, J., CURRY, F. E., Adamson, R. H., & Drenckhahn, D. (2004) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00687.2004 · Cited by 110
microRNA-124 Inhibits Migration and Invasion by Down-Regulating ROCK1 in Glioma
An, L., Liu, Y., Wu, A., & Guan, Y. (2013) · PLoS ONE · doi:10.1371/journal.pone.0069478 · Cited by 104
Cucurbitacin E inhibits breast tumor metastasis by suppressing cell migration and invasion
Zhang, T., Li, J., Dong, Y., Zhai, D., Lai, L., Dai, F., Deng, H., Chen, Y., Liu, M., & Yi, Z. (2012) · Breast Cancer Research and Treatment · doi:10.1007/s10549-012-2175-5 · Cited by 101
Actin binding proteins: Their ups and downs in metastatic life
Gross, S. R. (2013) · Cell Adhesion & Migration · doi:10.4161/cam.23176 · Cited by 101
Tannert, R., Milroy, L. ‐., Ellinger, B., Hu, T., Arndt, H., & Waldmann, H. (2010) · Journal of the American Chemical Society · doi:10.1021/ja9095126 · Cited by 100
The role of non-muscle myosin IIA in aggregation and invasion of human MCF-7 breast cancer cells
Derycke, L., Stove, C. P., Vercoutter‐Edouart, A., Wever, O. D., Dollé, L., Colpaert, N., Depypere, H., Michalski, J., & Bracke, M. (2011) · The International Journal of Developmental Biology · doi:10.1387/ijdb.113336ld · Cited by 98
Scott, V. R., Boehme, R. E., & Matthews, T. R. (1988) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.32.8.1154 · Cited by 95
Rho, ROCK and actomyosin contractility in metastasis as drug targets
Rodríguez‐Hernández, I., Cantelli, G., Fanshawe, B., & Sanz‐Moreno, V. (2016) · F1000Research · doi:10.12688/f1000research.7909.1 · Cited by 92
Self-citationThe structure of invadopodia in a complex 3D environment
Tolde, O., Rösel, D., Veselý, P., Folk, P., & Brábek, J. (2010) · European Journal of Cell Biology · doi:10.1016/j.ejcb.2010.04.003 · Cited by 89
Self-citationPharmacological inhibition of Rho-kinase signaling with Y-27632 blocks melanoma tumor growth
Routhier, A. A., Astuccio, M., Lahey, D., Monfredo, N., Johnson, A., Callahan, W., Partington, A., Fellows, K., Ouellette, L., Zhidro, S., et al. (2010) · Oncology Reports · doi:10.3892/or_00000708 · Cited by 88
Zhong, W.-B., Liang, Y.-C., Wang, C.-Y., Chang, T.-C., & Lee, W. S. (2005) · Endocrine Related Cancer · doi:10.1677/erc.1.01012 · Cited by 87
PTEN inhibits the invasion and metastasis of gastric cancer via downregulation of FAK expression
Zhang, L.-L., Liu, J., Shen, L., Zhang, J., Zhou, W., & Yu, H. (2014) · Cellular Signalling · doi:10.1016/j.cellsig.2014.01.025 · Cited by 79
Kaneko, K., Satoh, K., Masamune, A., Satoh, A., & Shimosegawa, T. (2002) · Pancreas · doi:10.1097/00006676-200201000-00005 · Cited by 78
Rab25 Regulates Invasion and Metastasis in Head and Neck Cancer
Amornphimoltham, P., Rechache, K. A., Thompson, J. L., Masedunskas, A., Leelahavanichkul, K., Patel, V., Molinolo, A., Gutkind, J. S., & Weigert, R. (2013) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-12-2858 · Cited by 78
Rho-kinase inhibitor, fasudil, suppresses glioblastoma cell line progression in vitro and in vivo
Deng, L., Li, G., Li, R., Liu, Q., He, Q., & Zhang, J. (2010) · Cancer Biology & Therapy · doi:10.4161/cbt.9.11.11634 · Cited by 77
Duxbury, M. S., Ashley, S. W., & Whang, E. E. (2003) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2003.12.031 · Cited by 75
Freitas, V. M., Rangel, M., Bisson, L. F., Jaeger, R. G., & Machado‐Santelli, G. M. (2008) · Journal of Cellular Physiology · doi:10.1002/jcp.21432 · Cited by 75
Sayed, K. A. E., Khanfar, M. A., Shallal, H. M., Muralidharan, A., Awate, B., Youssef, D. T. A., Liu, Y., Zhou, Y., Nagle, D. G., & Shah, G. V. (2008) · Journal of Natural Products · doi:10.1021/np070587w · Cited by 73
Effect of Cytoskeleton-Disrupting Agents on the Metastatic Behavior of Melanoma Cells 2 3
Hart, I. R., Raz, A., & Fidler, I. J. (1980) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/64.4.891 · Cited by 66
Lawler, K., Foran, E., O’Sullivan, G. C., Long, A., & Kenny, D. J. (2006) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.00626.2005 · Cited by 62
A novel small-molecule MRCK inhibitor blocks cancer cell invasion
Unbekandt, M., Croft, D. R., Crighton, D., Mezna, M., McArthur, D. R., McConnell, P., Schüttelkopf, A. W., Belshaw, S., Pannifer, A., Sime, M., et al. (2014) · Cell Communication and Signaling · doi:10.1186/s12964-014-0054-x · Cited by 62
Bousquet, P. F., Paulsen, L. A., Fondy, C., Lipski, K. M., Loucy, K. J., & Fondy, T. P. (1990) · PubMed · Cited by 62
The natural product cucurbitacin E inhibits depolymerization of actin filaments
Sörensen, P. M., Iacob, R. E., Fritzsche, M., Engen, J. R., Brieher, W. M., Charras, G., & Eggert, U. S. (2012) · ACS Chemical Biology · doi:10.1021/cb300254s · Cited by 61
In VitroGrowth Inhibitory Effects of Cytochalasins and Derivatives in Cancer Cells
Goietsenoven, G. V., Mathieu, V., Andolfi, A., Cimmino, A., Lefranc, F., Robert Kiss, A., & Evidente, A. (2010) · Planta Medica · doi:10.1055/s-0030-1250523 · Cited by 59
Exploiting the cytoskeletal filaments of neoplastic cells to potentiate a novel therapeutic approach
Trendowski, M. R. (2014) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2014.09.007 · Cited by 57
Kim, J. H., & Adelstein, R. S. (2011) · Journal of Cellular Physiology · doi:10.1002/jcp.22631 · Cited by 53
de Toledo, M., Anguille, C., Roger, L., Roux, P., & Gadéa, G. (2012) · PLoS ONE · doi:10.1371/journal.pone.0048344 · Cited by 52
Fagan‐Solis, K. D., Schneider, S. S., Pentecost, B. T., Bentley, B. A., Otis, C. N., Gierthy, J. F., & Arcaro, K. F. (2012) · Journal of Cellular Biochemistry · doi:10.1002/jcb.24480 · Cited by 48
Tohtong, R., Phattarasakul, K., Jiraviriyakul, A., & Suthiphongchai, T. (2003) · Prostate Cancer and Prostatic Diseases · doi:10.1038/sj.pcan.4500663 · Cited by 47
Zhu, F., Zhang, Z., Wu, G., Li, Z., Zhang, R., Ren, J., & Li, N. (2010) · Medical Oncology · doi:10.1007/s12032-010-9468-5 · Cited by 46
Fasudil Inhibits Lysophosphatidic Acid-Induced Invasiveness of Human Ovarian Cancer Cells
Ogata, S., Morishige, K., Sawada, K., Hashimoto, K., Mabuchi, S., Kawase, C., Ooyagi, C., Sakata, M., & Kimura, T. (2009) · International Journal of Gynecological Cancer · doi:10.1111/igc.0b013e3181c03909 · Cited by 46
Hakuma, N., Kinoshita, I., Shimizu, Y., Yamazaki, K., Yoshida, K., Nishimura, M., & Dosaka‐Akita, H. (2005) · Cancer Research · doi:10.1158/0008-5472.can-05-0060 · Cited by 45
Metastasis of aggressive amoeboid sarcoma cells is dependent on Rho/ROCK/MLC signaling
Kosla, J., Paňková, D., Plachý, J., Tolde, O., Bicanová, K., Dvořák, M., Rösel, D., & Brábek, J. (2013) · Cell Communication and Signaling · doi:10.1186/1478-811x-11-51 · Cited by 44
Self-citationIsoform-specific targeting of ROCK proteins in immune cells
Zanin‐Zhorov, A., Flynn, R. P., Waksal, S. D., & Blazar, B. R. (2016) · Small GTPases · doi:10.1080/21541248.2016.1181698 · Cited by 44
The Rho-kinase inhibitor inhibits proliferation and metastasis of small cell lung cancer
Yang, X., Di, J., Zhang, Y., Zhang, S., Lu, J., Liu, J., & Shi, W. (2011) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2011.11.011 · Cited by 43
Lyubchenko, T. A., Wurth, G. A., & Zweifach, A. (2003) · The Journal of Physiology · doi:10.1113/jphysiol.2002.033522 · Cited by 39
Nakashima, S., Tabuchi, K., SHIMOKAWA, S., Fukuyama, K., Mineta, T., & Abe, M. (1998) · Neurologia medico-chirurgica · doi:10.2176/nmc.38.805 · Cited by 39
Inhibiting myosin light chain kinase retards the growth of mammary and prostate cancer cells
Gu, L.-Z., Hu, W.-Y., Antic, N., Mehta, R. G., Turner, J. R., & de Lanerolle, P. (2006) · European Journal of Cancer · doi:10.1016/j.ejca.2005.12.017 · Cited by 39
Jasplakinolide: An Actin-Specific Reagent that Promotes Actin Polymerization
Holzinger, A. (2003) · Humana Press eBooks · doi:10.1385/1-59259-051-9:109 · Cited by 39
Takeuchi, H., Ara, G., Sausville, E. A., & Teicher, B. A. (1998) · Cancer Chemotherapy and Pharmacology · doi:10.1007/s002800050850 · Cited by 38
Khanfar, M. A., Youssef, D. T. A., & Sayed, K. A. E. (2009) · ChemMedChem · doi:10.1002/cmdc.200900430 · Cited by 38
Latrunculin with a Highly Oxidized Thiazolidinone Ring: Structure Assignment and Actin Docking
Ahmed, S. A., Odde, S., Daga, P. R., Bowling, J. J., Mesbah, M. K., Youssef, D. T. A., Khalifa, S. I., Doerksen, R. J., & Hamann, M. T. (2007) · Organic Letters · doi:10.1021/ol7020675 · Cited by 37
The real deal: using cytochalasin B in sonodynamic therapy to preferentially damage leukemia cells.
Trendowski, M. R., Yu, G., Wong, V., Acquafondata, C., Christen, T. D., & Fondy, T. P. (2014) · PubMed · Cited by 36
RhoA/ROCK signaling mediates plasticity of scirrhous gastric carcinoma motility
Matsuoka, T., Yashiro, M., Kato, Y., Shinto, O., Kashiwagi, S., & Hirakawa, K. (2011) · Clinical & Experimental Metastasis · doi:10.1007/s10585-011-9396-6 · Cited by 34
Mechanistic adaptability of cancer cells strongly affects anti-migratory drug efficacy
Sun, W., Lim, C. T., & Kurniawan, N. A. (2014) · Journal of The Royal Society Interface · doi:10.1098/rsif.2014.0638 · Cited by 34
Kale, V. P., Hengst, J. A., Desai, D. H., Dick, T. E., Choe, K. N., Colledge, A. L., Takahashi, Y., Sung, S., Amin, S., & Yun, J. K. (2014) · Cancer Letters · doi:10.1016/j.canlet.2014.08.032 · Cited by 34
The pharmacogenomics of drug resistance to protein kinase inhibitors
Gillis, N., & McLeod, H. L. (2016) · Drug Resistance Updates · doi:10.1016/j.drup.2016.06.008 · Cited by 33
Nummela, P., Yin, M., Kielosto, M., Leaner, V. D., Birrer, M. J., & Hölttä, E. (2006) · Cancer Research · doi:10.1158/0008-5472.can-05-2421 · Cited by 31
Wang, J., Liu, X., Yang, Z., Xie, B., & Zhong, Y.-S. (2014) · BMC Cancer · doi:10.1186/1471-2407-14-89 · Cited by 31
Enhancement of migration and invasion of hepatoma cells via a Rho GTPase signaling pathway
Wang, D., Dou, K., Li, K.-Z., & Song, Z. (2004) · World Journal of Gastroenterology · doi:10.3748/wjg.v10.i2.299 · Cited by 28
Vincristine potentiates cytochalasin B-induced DNA fragmentation in vitro
Kolber, M. A., & Hill, P. S. (1992) · Cancer Chemotherapy and Pharmacology · doi:10.1007/bf00686297 · Cited by 22
Prick, J. C. M., de Haan, G., Green, A. R., & Kent, D. G. (2014) · Experimental Hematology · doi:10.1016/j.exphem.2014.07.268 · Cited by 21
In vivo Effects in Melanoma of ROCK Inhibition-Induced FasL Overexpression
Teiti, I., Bertrand, F. A., Pich-Bavastro, C., Gence, R., Lajoie‐Mazenc, I., Rochaix, P., Favre, G., & Tilkin‐Mariamé, A. (2015) · Frontiers in Oncology · doi:10.3389/fonc.2015.00156 · Cited by 19
Translation in solid cancer: are size‐based response criteria an anachronism?
Fernandes, M., Rösel, D., & Brábek, J. (2014) · Clinical & Translational Oncology · doi:10.1007/s12094-014-1207-5 · Cited by 19
Self-citationWang, Z., Yang, D.-S., Liu, J., Liu, H., Ye, M., & Zhang, Y. (2015) · Tumor Biology · doi:10.1007/s13277-015-4115-6 · Cited by 17
Rho-kinase Inhibitors: Pharmacomodulations on the Lead Compound Y-32885
Logé, C., Wallez, V., Scalbert, E., Cario-Tourmaniantz, C., Loirand, G., Pacaud, P., & Lesieur, D. (2002) · Journal of Enzyme Inhibition and Medicinal Chemistry · doi:10.1080/1475636021000005659 · Cited by 17
Brábek, J. (2010) · International Journal of Oncology · doi:10.3892/ijo_00000560 · Cited by 15
Self-citationEffect of cytoskeleton-disrupting agents on the metastatic behavior of melanoma cells.
Hart, I. R., Raz, A., & Fidler, I. J. (1980) · The Mouseion at the JAXlibrary (Jackson Laboratory) · Cited by 15
Drugs for solid cancer the productivity crisis prompts a rethink
Brábek, J., Rösel, Veselý, P., & Fernandes, M. (2013) · OncoTargets and Therapy · doi:10.2147/ott.s45177 · Cited by 13
Self-citationHA-1077 inhibits cell migration/invasion of oral squamous cell carcinoma
Carboni, S. D. S. C. M., Lima, N. A. R., Pinheiro, N. M., Tavares‐Murta, B. M., & Crema, V. O. (2015) · Anti-Cancer Drugs · doi:10.1097/cad.0000000000000267 · Cited by 11
A first-in-human study of the dual ROCK I/II inhibitor, AT13148, in patients with advanced cancers.
Papadatos-Pastos, D., Kumar, R., Yap, T. A., Ruddle, R. R., Decordova, S., Jones, P. S., Halbert, G., Garrett, M. D., McLeod, R., Backholer, Z., et al. (2015) · Journal of Clinical Oncology · doi:10.1200/jco.2015.33.15_suppl.2566 · Cited by 9
Tashiro, E., & Imoto, M. (2016) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2016.04.014 · Cited by 8
Cited by
Mutational drivers of cancer cell migration and invasion
Novikov, N. M., Zolotaryova, S. Y., Gautreau, A. M., & Denisov, E. V. (2021) · British Journal of Cancer · doi:10.1038/s41416-020-01149-0 · Cited by 302
Cell swelling, softening and invasion in a three-dimensional breast cancer model
Han, Y. L., Pegoraro, A. F., Li, H., Li, K., Yuan, Y., Xu, G., Gu, Z., Sun, J., Hao, Y., Gupta, S. K., et al. (2020) · Nature Physics · doi:10.1038/s41567-019-0680-8 · Cited by 276
Microtubule-targeting agents and their impact on cancer treatment
Čermák, V., Dostál, V., Jelínek, M., Libusová, L., Kovář, J., Rösel, D., & Brábek, J. (2020) · European Journal of Cell Biology · doi:10.1016/j.ejcb.2020.151075 · Cited by 275
Self-citationRho GTPase signaling in cancer progression and dissemination
Crosas-Molist, E., Samain, R., Kohlhammer, L., Orgaz, J. L., George, S. L., Maiques, O., Barcelo, J., & Sanz-Moreno, V. (2022) · Physiological Reviews · doi:10.1152/physrev.00045.2020 · Cited by 272
Self-citationVimentin Intermediate Filaments as Potential Target for Cancer Treatment
Strouhalova, K., Přechová, M., Gandalovičová, A., Brábek, J., Gregor, M., & Rosel, D. (2020) · Cancers · doi:10.3390/cancers12010184 · Cited by 255
Self-citation
Metadata
- Authors
- Gandalovičová, A., Rosel, D., Fernandes, M., Veselý, P., Heneberg, P., Čermák, V., Petruželka, L., Kumar, S., Sanz-Moreno, V., & Brábek, J.
- Venue
- Trends in Cancer
- Publisher
- Elsevier BV
- Published
- 2017-06
- Volume
- 3
- Issue
- 6
- Pages
- 391-406
- ISSN
- 2405-8025 (ISSN-L)
- 2405-8033
- OpenAlex
- W2614388893
- Cited by
- 351
- References
- 120
- FWCI
- 2.09
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.